Leonard Post News Today

Rakovina Therapeutics Inc. , ("Rakovina" or the "Company"), a biopharmaceutical company dedicated to improving the lives of cancer patients through the development of novel DNA-damage response inhibitor therapeutics, is pleased to announce a...

Company Leveraging Deep Docking AI Drug Discovery PlatformVANCOUVER, British Columbia, March 27, 2024 -- Rakovina Therapeutics Inc. , , a biopharmaceutical company dedicated to improving the lives...

FLGT earnings call for the period ending June 30, 2022.

Fulgent Genetics, Inc. (NASDAQ:NASDAQ:FLGT) Q2 2022 Results Earnings Conference Call August 4, 2022, 04:30 PM ET Company Participants Nicole Borsje - Investor Relations, The Blueshirt Group...

Fulgent Genetics Welcomes Dr. Michael Nohaile and Dr. Leonard Post to Board of Directors - read this article along with other careers information, tips and advice on BioSpace

Share this article Share this article SAN MATEO, Calif., May 4, 2021 /PRNewswire/ -- Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class therapies targeting the Hippo pathway, announced today the completion of enrollment of the first cohort of patients being treated with VT3989 in its Phase 1 clinical study. The Company anticipates enrolling the next higher dose cohort in the second part of May.   The VT3989 Phase 1 study is now open at cent...

Athena Therapeutics Announces Initial Financing From HighCape Capital And Connecticut Innovations Share Article NEW HAVEN, Conn. (PRWEB) December 17, 2020 Athena Therapeutics today announced the closing of an initial financing round with HighCape Capital and Connecticut Innovations. This round of funding will provide the necessary resources to create an innovative cancer drug company that combines world-class scientists, powerful ...